Clinical trial
ORACLE: Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology
NCT06325020 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ORACLE: Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology
- Lead sponsor
- University of Edinburgh
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 4, 2024
- Completion date
- December 31, 2026
- Enrollment
- 500 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.